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A review of the factors historically thought to contribute to the feminization of men with Laennecs
cirrhosis is presented. Objective scientific data is presented both in support ofand in rejection ofsuchfactors
when available. Recent hypotheses about the significance of an altered estrogen to androgen (E/T) ratio as
being important in the pathogenesis of feminization also are discussed. Finally, a hypothesis which
incorporates the findings of hypogonadism and cirrhosis with portal-systemic shunting is presented as a
pathogenic mechanism for the feminization of men with alcohol-induced Laennec's cirrhosis.
Chronic alcoholic men frequently demonstrate evidence for hypogonadism and
feminization [1]. The hypogonadism in these men is manifested bytesticular atrophy,
a high prevalence ofinfertility, loss oflibido, impotence, and reduced plasma levels of
testosterone. Feminization is distinct from hypogonadism and is manifested by
gynecomastia, female body habitus changes, the presence of spider angiomata,
palmar erythema, and changes in body hair patterns.
It has been demonstrated both clinically and in the laboratory, using a variety of
animal models, that alcohol abuse per se in the absence of significant (irreversible)
liver disease is responsible for the hypogonadism observed in alcoholic men [1-3].
Feminization on the other hand occurs later in the course of chronic alcoholism and
is seen only occasionally in an alcoholic individual without demonstrable liver
disease. Moreover the pathogenesis of alcohol-induced hypogonadism, although
incompletely understood, particularly at a molecular level, has been shown to be due
both to an alcohol-induced primary gonadal injury and to an alcohol-associated
hypothalamic-pituitary dysfunction [4-6]. In contrast, the pathogenesis of the
feminization of chronic alcoholic men is understood poorly if at all [1].
It is the purpose ofthis paper to present a historical review of the factors thought
possibly to contribute to this feminization and then to present the author's own
prejudice as to its pathogenesis. Clinical and experimental data used to derive the
various historical hypotheses as well as the author's own prejudices will be discussed
wherever possible.
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The earliest proposed mechanism for the development of gynecomastia, the most
obvious sign of feminization in chronic alcoholic men, was that either an estrogenic
material or an inflammatory agent present in the diet of such men accumulated in the
blood presumably as a consequence of reduced hepatic function [7]. Such retained
material was thought to cause the breast tissue to hypertrophy and thus produce the
physical finding of gynecomastia. Soon after biochemists and endocrinologists were
able to isolate and synthesize individual steroids, it was demonstrated that: (a)
estrogenic substances when administered to normal men could produce feminization,
and (b) the liver was essential to the normal metabolic handling of sex steroids. Soon
thereafter, it was demonstrated that the infusion of pharmacological amounts of
steroidal estrogens could produce spider angiomata, palmar erythema, gynecomastia,
and testicular atrophy both in man and in experimental animals [8-10]. Moreover, it
was shown that there existed a reversible reduced hepatic clearance of estrogens in
acute hepatitis[11]. As a result of these individual observations, it was proposed that
feminization occurred in alcoholic men as a consequence of alcohol-induced liver
disease with the resultant prehepatic retention of estrogens.
With the development of sensitive radioimmunoassay methods to directly measure
the plasma levels of estrogens in man our understanding of the pathogenesis of
feminization, rather than becoming clearer as a result of biochemical confirmation of
increased plasma estrogenlevels, became less clear as the initial reports found normal
rather than increased levels of estradiol in cirrhotic men [4,11-15]. Moreover, the
metabolic clearance rate of estradiol in cirrhotic men was found to be normal, not
reduced [15]. Undaunted by these disturbing findings, other investigators turned to
measuring the levels of weaker plasma estrogens such as estrone, while yet others
began to measure levels of free plasma estradiol [13,16-18]. Although such investiga-
tions universally found increased levels of estrone, some [13] but not all [1 1,17,18]
found increased levels of free estradiol and the matter was far from resolved. Three
factors have confounded the resolution: (1) estrone has only one-fourth the biological
potency of estradiol and the increases found for estrone, although definite, were not
of major proportions; (b) plasma levels of sex steroid binding globulin when
measured have universally been reported to be increased [4,11,14,16,19]; and (c) there
are definite problems with the methodology, performance, and interpretation of
studies directed at determining concentrations of free plasma steroid levels.
Despite the accumulation of such negative scientific data, the clinical observation
remains that feminization occurs rarely except in alcoholics with liver disease and to
an even lesser extent in some individuals with non-alcoholic cirrhosis. Thus liver
disease, particularly cirrhosis, must have some pathogenic role in the development of
feminization. The specific mechanism, however, has not yet been identified. Thus
other approaches have continued to receive support.
A potential role for the pituitary hormone prolactin in the feminization of
alcoholic cirrhotic men was proposed as soon as increased levels of this hormone
were found to occur in such men [16]. The observation that such men, in addition to
having increased basal levels ofprolactin, also had lost the normal diurnal variation
in plasma prolactin levels seemed to provide yet more credibility to a potential role
for prolactin in the pathogenesis of the observed feminization [20]. Moreover, the
statistically significant association between the presence of clinically apparent
gynecomastia and increased prolactin levels provided additional support for such a
role for prolactin [16]. Not long thereafter, however, it became apparent that
prolactin is an estrogen-responsive hormone and soon the question naturally was
asked whether the observed increases wereprimary(i.e., responsible for the feminiza-
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tion) or merely another secondary derivative response of hyperestrogenization (i.e.,
feminization) [21]. This question took on additional import as the role ofprolactin in
the genesis of gynecomastia came into question [22]. The present consensus among
endocrinologists is that hyperprolactinemia per se is not capable of producing
gynecomastia. This opinion is based upon the clinical observation that gynecomastia
is unusual if not rare in individuals with hyperprolactinemia associated with pituitary
adenoma or other neuroendocrine disease states. Moreover the gynecomastia found
in association with hepatic diseases is characterized by proliferation of the stroma
and ducts but not of the acini [23]. The ducts and stroma are known to be estrogen-
responsive while the acini respond to progesterone and, to a lesser extent, prolactin
under the influence of estrogen [24]. Gynecomastia is thought, therefore, to develop
only in individuals who either have overt hyperestrogenemia or those who are
exposed to weak non-steroidal estrogen agonists or androgen antagonists. Prolactin,
however, may act synergistically with such materials and thereby contribute to
enhanced breast hypertrophy.
With answers to resolve this dilemma not forthcoming in retrospective studies
involving cirrhotic men, the possibility that feminization might occur in these men as
a result of an altered estrogen-androgen ratio was advanced [13]. With the observa-
tion that in chronic alcoholic men estradiol levels are either normal or increased and
that estrone levels are definitely increased while testosterone levels are reduced, it
must be obvious that such a ratio would be markedly increased in alcoholic men
when compared to such a ratio in normal non-alcoholic men. This hypothesis,
however, has theoretical if not real problems in its general application to the problem
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of feminization of alcoholic men. Clinically older men (above 60 years of age) have
reduced testosterone production and plasma levels as well as normal to increased
levels of estrogens and therefore an abnormally increased estrogen to androgen ratio.
They are, however, not feminized as a group. At a more scientific or theoretical level,
steroid receptors, be they estrogen or androgen receptors, respond to concentrations
of individual steroids, not to ratios of steroid. They are quite species specific. Thus
androgen receptors recognize androgens but not estrogens while estrogen receptors
recognize estrogens but not androgens. Therefore, when the calculated estrogen/an-
drogen ratio is composed of a minimal to moderate increase in the numerator
(estrogen) and a moderate to marked decrease in the denominator (androgen) it is
quite problematical as to whether or not such a ratio has any real biological
significance in terms of increased feminization.
With all of the preceding negativism it is not unreasonable at this point to ask what
then does the author think might be a reasonable explanation for the observed
feminization in chronic alcoholic men. Before stating my own prejudice I would like
to provide the reader with some background information. Recent studies and several
clinical observations suggest that a degree of adrenal-cortical hyperactivity exists in
chronic alcoholic men [25-31]. Therefore, an increased incidence of Cushing's
syndrome and increased plasma levels of androstenedione, a weak androgen princi-
pally of adrenal cortical origin, have been reported to occur in chronic alcoholics.
Moreover, adrenal androgens such as androstenedione and dehydroepiandrosterone
are capable of being aromatized in a variety of tissues such as skin, fat, bone, muscle,
brain, and liver' to estrogens, particularly estrone and to a lesser extent estradiol
[32-37]. Such peripheral aromatization is known to occur in normal men and has
been shown to be increased in chronic alcoholic men, particularly those with cirrhosis
[38,39]. Thus, peripheral aromatization of such weak adrenal androgens secreted in
excess by alcoholic men would maintain normal to only moderately increased levels
of such androgenic steroids while maintaining normal estradiol and increased estrone
levels in men with gonadal atrophy. Such a formulation is consistent with the normal
metabolic clearance rate and increased plasma production rate of androstenedione as
well as the normal metabolic clearance and increased plasma production rates for
both estrone and estradiol reported in cirrhotic men [15,26,29-31]. Thus, it has been
demonstrated that an increased peripheral conversion of testosterone and andro-
stenedione to estradiol and estrone, respectively, can account for at least 60 percent
of the plasma level of each of these estrogens in cirrhotic men [30].
It is well known that cirrhosis, particularly Laennec's cirrhosis due to chronic
alcohol abuse, is associated both with testicular atrophy and with portal hypertension
and the development of portal systemic shunts. In addition it has been demonstrated
that steroids, once cleared from plasma, normally undergo an enterohepatic circula-
tion. Putting all of these rather diffuse observations together, I would propose that
alcoholic men with cirrhosis clear the plasma of estrogens and androgens as well as
normal individuals and further, that these hepatically extracted steroids are conju-
gated and then excreted not only into blood for ultimate urinary excretion but also
into bile where they gain access to gut. Once within the gut these steroids are
deconjugated and reabsorbed. Normally such reabsorbed steroids are rapidly re-
moved from the portal venous blood by the liver and are reexcreted into bile without
altering systemic steroid levels. However, in the individual with cirrhosis and
hypogonadism due to alcohol-induced gonadal injury as well as portal hypertension
with portal-systemic shunting either around or through the liver, such reabsorbed
steroids gain access to the systemic circulation and therefore contribute to the
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systemic levels of these steroids, thus maintaining systemic estradiol, estrone, and
androstenedione levels at normal to moderately increased levels despite advanced
gonad failure and reduced production rates. Such reabsorbed steroids are either then
capable ofdirectly acting at peripheral tissues as estrogens (estrone and estradiol) or
can be converted, as in the case of androstenedione, to an estrogen (estrone). Such
peripheral intracellular conversion of androstenedione to estrone can occur without
even altering systemic plasma estrogen levels. Such a formulation is at least
consistent with the observation of similar plasma levels of estradiol in cirrhotic men
who have gynecomastia when compared to cirrhotic men without gynecomastia
[1,4,14,22,27].
Preliminary studies in ourlaboratory using the rat model ofchronic alcoholism are
consistent also with such a formulation [40]. Specifically, alcohol feeding has been
shown to be associated with increased plasma levels of corticosterone suggesting
increased adrenal-cortical secretory activity as compared to ad lib fed animals. In
addition, animals with artificially produced portal hypertension and presumed portal
systemic shunts as a consequence ofpartial portal veinligation have increased plasma
levels of estrone (which presumably arises as a result of peripheral conversion of
androstenedione) whether or not they are fed alcohol [40]. Thus the combination of
alcohol feeding and the development of portosystemic shunts due to partial portal
vein ligation in male rats is associated with the finding ofincreased adrenal-cortical
secretory activity, manifested by increased corticosterone and presumably andro-
stenedione levels as well as increased estrone levels, normal estradiol levels, and
reduced testosterone levels.
Finally, additional studies actively in progress in our laboratory suggest that the
net effect of reduced gonadal androgen production with resultant reduced plasma
levels of testosterone and increased estrogen levels due to peripheral conversion of
weak adrenal androgens to estrogens may alter tissue sensitivity to estrogens [41-43].
Because the combination of hypogonadism and hyperestrogenization frequently
occurs in individuals with alcohol-induced liver disease but rarely in other forms of
chronic liver disease, the presence of these two phenomena together in individuals
with Laennec's cirrhosis may explain the frequent finding of feminization in such
individuals but not in individuals with other equally advanced liver disease not
associated with gonadal injury.
The ease with which all of the available data accumulated by investigators in
different laboratories can be incorporated into a formulation which incorporates an
altered enterohepatic circulation of biliary excreted steroids as a result of portal
hypertension and primary liver disease makes it an attractive working hypothesis.
Clearly, much more work will be needed either to validate or reject such a
formulation. Until such data is available, however, it seems a likely candidate as an
accurate explanation for the feminization in alcoholic men with cirrhosis.
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